JAN 26, 2021 11:25 AM PST

Diagnostic Tool Could ID 20% of Autism Cases

WRITTEN BY: Carmen Leitch

Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disorder cases. If developed, such a test could allow for early intervention that may enable clinicians to improve outcomes for affected individuals and their families.

Image credit: Pxhere

Autoantibodies are antibodies that act against the cells of one's own body, sometimes as part of normal housekeeping or other functions, but sometimes erroneously. Maternal autoantibodies that are thought to act against proteins in the developing fetus have also been associated with autism spectrum disorder (ASD). In one study, researchers linked specific maternal autoantibodies to certain features of autism, like significantly impaired language skills for some autoantibodies, and increased levels of irritability for others.

This new study, which was reported Molecular Psychiatry, used computational tools to analyze biological samples from 450 moms of kids with ASD and 342 moms of typically-developing kids. This work identified autoantibodies that react with eight abundant fetal brain proteins, and the researchers used this data to create a diagnostic tool.

"The implications from this study are tremendous. It's the first time that machine learning has been used to identify with 100 percent accuracy MAR (maternal autoantibody-related) ASD-specific patterns as potential biomarkers of ASD risk," said lead study author Judy Van de Water, a professor of rheumatology, allergy, and clinical immunology at the University of California. Davis.

"The big deal about this particular study is that we created a new, very translatable test for future clinical use," added Van de Water. This test uses maternal blood samples in an ELISA platform.

Previous work by this group showed that maternal autoantibodies reacted with seven proteins in the developing brain of the fetus including collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2), guanine deaminase (GDA), and stress-induced phosphoprotein-1 (STIP1). In this study, the three top reactivity patterns associated with MAR ASD were identified as CRMP1+GDA, CRMP1+CRMP2, and NSE+STIP1. CRIMP1+GDA was the most commonly identified pattern.

"For example, if the mother has autoantibodies to CRIMP1 and GDA, her odds of having a child with autism is 31 times greater than the general population, based on this current dataset. That's huge," explained Van de Water. "There's very little out there that is going to give you that type of risk assessment."

The presence of CRIMP1 was linked to a greater likelihood of severe ASD cases as well.

"We can envision that a woman could have a blood test for these antibodies prior to getting pregnant. If she had them, she'd know she would be at very high risk of having a child with autism. If not, she has a 43 percent lower chance of having a child with autism as MAR autism is ruled out," Van de Water said.

Van de Water also wants to know more about the physiological impact of maternal autoantibodies and is using animal models to investigate. "We will also use these animal models to develop therapeutic strategies to block the maternal autoantibodies from the fetus," she added. "This study is a big deal in terms of early risk assessment for autism, and we're hoping that this technology will become something that will be clinically useful in the future."

Sources: AAAS/Eurekalert! via University of California - Davis Health, Molecular Psychiatry

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 08, 2021
Microbiology
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
AUG 08, 2021
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
Researchers recently discovered bacteria that fed on the element manganese. Scientists also know that some bacterial pat ...
AUG 08, 2021
Drug Discovery & Development
Light Therapy Accelerates Healing in Burn Injuries
AUG 08, 2021
Light Therapy Accelerates Healing in Burn Injuries
Photobiomodulation therapy (PBM), a form of low-dose light therapy, can speed up recovery from burns and reduce inflamma ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
SEP 23, 2021
Cell & Molecular Biology
A New DNA Editor Hidden in a Microbial Jumping Gene
SEP 23, 2021
A New DNA Editor Hidden in a Microbial Jumping Gene
The technology for CRISPR originated in a bacterial immune defense system. Now, the team of one of the researchers who h ...
SEP 24, 2021
Chemistry & Physics
Protecting the Mango Plant with Signal Interference
SEP 24, 2021
Protecting the Mango Plant with Signal Interference
Researchers made huge steps in mitigating the virulence of a mango plant toxin by exploiting the bacteria and signal pat ...
Loading Comments...